Vitamin a derivatives as treatment options for retinal degenerative diseases

Nutrients

Volumn 5, Issue 7, 2013, Pages 2466-2666

  Perusek, Lindsay ^a   Maeda, Tadao ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

11 cis retinal; 9 cis retinyl acetate; All trans retinol; Carotenoids; Leber congenital amaurosis; Photoreceptor; Retina; Retinal pigmented epithelium; Visual cycle; Vitamin A

Indexed keywords

11 CIS RETINAL; 9 CIS CAROTENE; 9 CIS RETINAL; 9 CIS RETINOL ACETATE; ALITRETINOIN; ALPHA CAROTENE; BETA CAROTENE; LECITHIN RETINOL ACYLTRANSFERASE; PREALBUMIN; QLT 091001; RETINOID DERIVATIVE; RETINOL BINDING PROTEIN; RETINOL DERIVATIVE; RETINOL ESTER; SCOTOPSIN; TRANSDUCIN; UNCLASSIFIED DRUG; ACYLTRANSFERASE; CIS TRANS ISOMERASE; LECITHIN-RETINOL ACYLTRANSFERASE; RETINAL; RETINOID ISOMEROHYDROLASE; RETINOL; VISUAL PIGMENT;

DRUG STRUCTURE; ELECTRORETINOGRAM; ESTERIFICATION; EYE FUNDUS ALBIPUNCTATUS; GENE; GENE MUTATION; HUMAN; HYPERCALCEMIA; LEBER CONGENITAL AMAUROSIS; LIVER CIRRHOSIS; LIVER FIBROSIS; MUELLER CELL; NONHUMAN; OSTEOLYSIS; PATHOPHYSIOLOGY; PHOTORECEPTOR; PHOTOTRANSDUCTION; PIGMENT EPITHELIUM; RETINA CONE; RETINA DEGENERATION; RETINITIS PIGMENTOSA; RETINOIC ACID GENE 6; RETINOL INTOXICATION; REVIEW; SIDE EFFECT; VITAMIN METABOLISM; ANALOGS AND DERIVATIVES; ANIMAL; CLINICAL TRIAL (TOPIC); DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; GENETICS; METABOLISM; RETINA; RETINAL DISEASES; VISION;

ANIMALIA;

ACYLTRANSFERASES; ANIMALS; CIS-TRANS-ISOMERASES; CLINICAL TRIALS AS TOPIC; DISEASE MODELS, ANIMAL; HUMANS; RETINA; RETINAL DISEASES; RETINAL PIGMENTS; RETINALDEHYDE; VISION, OCULAR; VITAMIN A;

EID: 84893200167     PISSN: 20726643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (112)

1. Sommer, A.; Vyas, K.S. A global clinical view on vitamin A and carotenoids. Am. J. Clin. Nutr. 2012, 96, 1204S-1206S.
2. Duester, G. Retinoic acid synthesis and signaling during early organogenesis. Cell 2008, 134, 921-931.
3. Oren, T.; Sher, J.A.; Evans, T. Hematopoiesis and retinoids: Development and disease. Leuk. Lymphoma 2003, 44, 1881-1891.
4. Wald, G. Molecular basis of visual excitation. Science 1968, 162, 230-239.
5. Rhinn, M.; Dolle, P. Retinoic acid signalling during development. Development. 2012, 139, 843-858.
6. Plack, P.A, Occurrence, absorption and distribution of vitamin A. Proc. Nutr. Soc. 1965, 24, 146-153.
7. Gaucheron, F. Milk and dairy products: A unique micronutrient combination. J. Am. Coll. Nutr. 2011, 30, 400S-409S.
8. Thurnham, D.I.; Northrop-Clewes, C.A. Optimal nutrition: Vitamin A and the carotenoids. Proc. Nutr. Soc. 1999, 58, 449-457.
9. Allen, L.H. To what extent can food-based approaches improve micronutrient status? Asia Pac. J. Clin. Nutr. 2008, 17, 103-105.
10. Dew, S.E.; Ong, D.E. Specificity of the retinol transporter of the rat small intestine brush border. Biochemistry 1994, 33, 12340-12345.
11. Vachali, P.; Bhosale, P.; Bernstein, P.S. Microbial carotenoids. Methods Mol. Biol. 2012, 898, 41-59.
12. Bernstein, P.S., Yoshida, M.D., Katz, N.B.; McClane, R.W., Gellermann, W. Raman detection of macular carotenoid pigments in intact human retina. Investig. Ophthalmol. Vis. Sci. 1998, 39, 2003-2011.
13. Moore, T. Vitamin A and carotene: The absence of the liver oil vitamin A from carotene. VI. The conversion of carotene to vitamin A in vivo. Biochem. J. 1930, 24, 692-702.
14. Amengual, J.; Lobo, G.P.; Golczak, M.; Li, H.N.; Klimova, T.; Hoppel, C.L.; Wyss, A., Palczewski, K.; von Lintig, J. A mitochondrial enzyme degrades carotenoids and protects against oxidative stress. FASEB J. 2011, 25, 948-959.
15. Hu, K.Q.; Liu, C., Ernst, H., Krinsky, N.I.; Russell, R.M.; Wang, X.D. The biochemical characterization of ferret carotene-9',10'-monooxygenase catalyzing cleavage of carotenoids in vitro and in vivo. J. Biol. Chem. 2006, 281, 19327-19338.
16. Lietz, G.; Oxley, A.; Boesch-Saadatmandi, C.; Kobayashi, D. Importance of beta,beta-carotene 15,15′-monooxygenase 1 (BCMO1) and beta,beta-carotene 9′,10′-dioxygenase 2 (BCDO2) in nutrition and health. Mol. Nutr. Food Res. 2012, 56, 241-250.
17. Lobo, G.P.; Hessel, S.; Eichinger, A.; Noy, N.; Moise, A.R.; Wyss, A.; Palczewski, K.; von Lintig, J. ISX is a retinoic acid-sensitive gatekeeper that controls intestinal ß,ß-carotene absorption and vitamin A production. FASEB J. 2010, 24, 1656-1666.
18. Seino, Y.; Miki, T.; Kiyonari, H.; Abe, T.; Fujimoto, W.; Kimura, K.; Takeuchi, A.; Takahashi, Y.; Oiso, Y.; Iwanaga, T.; et al. Isx participates in the maintenance of vitamin A metabolism by regulation of beta-carotene 15,15′-monooxygenase (Bcmo1) expression. J. Biol. Chem. 2008, 283, 4905-4911.
19. O'Neill, M.E.; Thurnham, D.I. Intestinal absorption of beta-carotene, lycopene and lutein in men and women following a standard meal: Response curves in the triacylglycerol-rich lipoprotein fraction. Br. J. Nutr. 1998, 79, 149-159.
20. Rigtrup, K.M.; Kakkad, B.; Ong, D.E. Purification and partial characterization of a retinyl ester hydrolase from the brush border of rat small intestine mucosa: Probable identity with brush border phospholipase B. Biochemistry 1994, 33, 2661-2666.
21. Ong, D.E. Cellular transport and metabolism of vitamin A: Roles of the cellular retinoid-binding proteins. Nutr. Rev. 1994, 52, S24-S31.
22. Li, E.; Norris, A.W. Structure/function of cytoplasmic vitamin A-binding proteins. Annu. Rev. Nutr. 1996, 16, 205-234.
23. Newcomer, M.E.; Jamison, R.S.; Ong, D.E. Structure and function of retinoid-binding proteins. Subcell. Biochem.1998, 30, 53-80.
24. Piantedosi, R.; Ghyselinck, N.; Blaner, W.S.; Vogel, S. Cellular retinol-binding protein type III is needed for retinoid incorporation into milk. J. Biol. Chem. 2005, 280, 24286-24292.
25. Blomhoff, R.; Green, M.H.; Berg, T.; Norum, K.R. Transport and storage of vitamin A. Science 1990, 250, 399-404.
26. Redgrave, T.G. Chylomicron metabolism. Biochem. Soc. Trans. 2004, 32, 79-82.
27. Goodman, D.W.; Huang, H.S.; Shiratori, T. Tissue distribution and metabolism of newly absorbed vitamin A in the rat. J. Lipid Res. 1965, 6, 390-396.
28. Van Bennekum, A.M.; Kako, Y.; Weinstock, P.H.; Harrison, E.H.; Deckelbaum, R.J.; Goldberg, I.J.; Blaner, W.S. Lipoprotein lipase expression level influences tissue clearance of chylomicron retinyl ester. J. Lipid Res. 1999, 40, 565-574.
29. MacDonald, P.N.; Ong, D.E. Evidence for a lecithin-retinol acyltransferase activity in the rat small intestine. J. Biol. Chem. 1988, 263, 12478-12482.
30. O'Byrne, S.M.; Wongsiriroj, N.; Libien, J.; Vogel, S.; Goldberg, I.J.; Baehr, W.; Palczewski, K.; Blaner, W.S. Retinoid absorption and storage is impaired in mice lacking lecithin: Retinol acyltransferase (LRAT). J. Biol. Chem. 2005, 280, 35647-35657.
31. Orban, T.; Palczewska, G.; Palczewski, K. Retinyl ester storage particles (Retinosomes) from the retinal pigmented epithelium resemble lipid droplets in other tissues. J. Biol. Chem. 2011, 286, 17248-17258.
32. Frey, S.K.; Vogel, S. Vitamin A metabolism and adipose tissue biology. Nutrients 2011, 3, 27-39.
33. Chytil, F. The lungs and vitamin A. Am. J. Physiol. 1992, 262, L517-L527.
34. Quadro, L.; Blaner, W.S.; Salchow, D.J.; Vogel, S.; Piantedosi, R.; Gouras, P.; Freeman, S.; Cosma, M.P.; Colantuoni, V.; Gottesman, M.E. Impaired retinal function and vitamin A availability in mice lacking retinol-binding protein. EMBO J. 1999, 18, 4633-4644.
35. Seeliger, M.W.; Biesalski, H.K.; Wissinger, B.; Gollnick, H.; Gielen, S.; Frank, J.; Beck, S.; Zrenner, E. Phenotype in retinol deficiency due to a hereditary defect in retinol binding protein synthesis. Investig. Ophthalmol. Vis. Sci. 1999, 40, 3-11.
36. Wolf, G. Retinol transport and metabolism in transthyretin-"knockout" mice. Nutr. Rev. 1995, 53, 98-99.
37. Zanotti, G.; Berni, R. Plasma retinol-binding protein: Structure and interactions with retinol, retinoids, and transthyretin. Vitam. Horm. 2004, 69, 271-295.
38. Kawaguchi, R.; Yu, J.; Honda, J.; Hu, J.; Whitelegge, J.; Ping, P.; Wiita, P.; Bok, D.; Sun, H. A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A. Science 2007, 315, 820-825.
39. Pasutto, F.; Sticht, H.; Hammersen, G.; Gillessen-Kaesbach, G.; Fitzpatrick, D.R.; Nürnberg, G.; Brasch, F.; Schirmer-Zimmermann, H.; Tolmie, J.L.; Chitayat, D.; et al. Mutations in STRA6 cause a broad spectrum of malformations including anophthalmia, congenital heart defects, diaphragmatic hernia, alveolar capillary dysplasia, lung hypoplasia, and mental retardation. Am. J. Hum. Genet. 2007, 80, 550-560.
40. White, T.; Lu, T.Y.; Metlapally, R.; Katowitz, J.; Kherani, F.; Wang, T.Y.; Tran-Viet, K.N.; Young, T.L. Identification of STRA6 and SKI sequence variants in patients with anophthalmia/microphthalmia. Mol. Vis. 2008, 14, 2458-2465.
41. Ruiz, A.; Mark, M.; Jacobs, H.; Klopfenstein, M.; Hu, J.; Lloyd, M.; Habib, S.; Tosha, C.; Radu, R.A.; Ghyselinck, N.B.; et al. Retinoid content, visual responses, and ocular morphology are compromised in the retinas of mice lacking the retinol-binding protein receptor, STRA6. Investig. Ophthalmol. Vis. Sci. 2012, 53, 3027-3039.
42. Saari, J.C. Vitamin A metabolism in rod and cone visual cycles. Annu. Rev. Nutr. 2012, 32, 125-145.
43. Maeda, A.; Maeda, T.; Imanishi, Y.; Golczak, M.; Moise, A.R.; Palczewski, K. Aberrant metabolites in mouse models of congenital blinding diseases, formation and storage of retinyl esters. Biochemistry 2006, 45, 4210-4219.
44. Imanishi, Y.; Batten, M.L.; Piston, D.W.; Baehr, W.; Palczewski, K. Noninvasive two-photon imaging reveals retinyl ester storage structures in the eye. J. Cell Biol. 2004, 164, 373-383.
45. Batten, M.L.; Imanishi, Y.; Maeda, T.; Tu, D.C.; Moise, A.R.; Bronson, D.; Possin, D.; van Gelder, R.N.; Baehr, W.; Palczewski, K. Lecithin-retinol acyltransferase is essential for accumulation of all-trans-retinyl esters in the eye and in the liver. J. Biol.Chem. 2004, 279, 10422-10432.
46. Gollapalli, D.R.; Rando, R.R. All-trans-retinyl esters are the substrates for isomerization in the vertebrate visual cycle. Biochemistry 2003, 42, 5809-5818.
47. Wang, J.S.; Estevez, M.E.; Cornwall, M.C.; Kefalov, V.J. Intra-retinal visual cycle required for rapid and complete cone dark adaptation. Nat. Neurosci. 2009, 12, 295-302.
48. Jones, G.J.; Crouch, R.K.; Wiggert, B.; Cornwall, M.C.; Chader, G.J. Retinoid requirements for recovery of sensitivity after visual-pigment bleaching in isolated photoreceptors. Proc. Natl. Acad. Sci. USA 1989, 86, 9606-9610.
49. Kefalov, V.J. Rod and cone visual pigments and phototransduction through pharmacological, genetic, and physiological approaches. J. Biol. Chem. 2012, 287, 1635-1641.
50. Wang, J.S.; Kefalov, V.J. The cone-specific visual cycle. Prog. Retin. Eye Res. 2011, 30, 115-128.
51. Trehan, A.; Canada, F.J.; Rando, R.R. Inhibitors of retinyl ester formation also prevent the biosynthesis of 11-cis-retinol. Biochemistry 1990, 29, 309-312.
52. Redmond, T.M.; Yu, S.; Lee, E.; Bok, D.; Hamasaki, D.; Chen, N.; Goletz, P.; Ma, J.X.; Crouch, R.K.; Pfeifer, K. Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle. Nat. Genet. 1998, 20, 344-351.
53. Parker, R.O.; Crouch, R.K. Retinol dehydrogenases (RDHs) in the visual cycle. Exp. Eye Res. 2010, 91, 788-792.
54. Rohrer, B.; Lohr, H.R.; Humphries, P.; Redmond, T.M.; Seeliger, M.W.; Crouch, R.K. Cone opsin mislocalization in Rpe65(-/-) mice: A defect that can be corrected by 11-cis retinal. Investig. Ophthalmol. Vis. Sci. 2005, 46, 3876-3882.
55. Driessen, C.A.; Winkens, H.J.; Hoffmann, K.; Kuhlmann, L.D.; Janssen, B.P.; van Vugt, A.H.; van Hooser, J.P.; Wieringa, B.E.; Deutman, A.F.; Palczewski, K.; et al. Disruption of the 11-cis-retinol dehydrogenase gene leads to accumulation of cis-retinols and cis-retinyl esters. Mol. Cell. Biol. 2000, 20, 4275-4287.
56. Gonzalez-Fernandez, F. Interphotoreceptor retinoid-binding protein-An old gene for new eyes. Vis. Res. 2003, 43, 3021-3036.
57. Wu, Q.; Blakeley, L.R.; Cornwall, M.C.; Crouch, R.K.; Wiggert, B.N.; Koutalos, Y. Interphotoreceptor retinoid-binding protein is the physiologically relevant carrier that removes retinol from rod photoreceptor outer segments. Biochemistry 2007, 46, 8669-8679.
58. Jin, M.; Li, S.; Nusinowitz, S.; Lloyd, M.; Hu, J.; Radu, R.A.; Bok, D.; Travis, G.H. The role of interphotoreceptor retinoid-binding protein on the translocation of visual retinoids and function of cone photoreceptors. J. Neurosci. 2009, 29,1486-1495.
59. Parker, R.O.; Fan, J.; Nickerson, J.M.; Liou, G.I.; Crouch, R.K. Normal cone function requires the interphotoreceptor retinoid binding protein. J. Neurosci. 2009, 29, 4616-4621.
60. Wisard, J.; Faulkner, A.; Chrenek, M.A.; Waxweiler, T.; Waxweiler, W.; Donmoyer, C.; Liou, G.I.; Craft, C.M.; Schmid, G.F.; Boatright, J.H.; et al. Exaggerated eye growth in IRBP-deficient mice in early development. Investig. Ophthalmol. Vis. Sci. 2011, 52, 5804-5811.
61. Garlipp, M.A.; Gonzalez-Fernandez, F. Cone outer segment and Muller microvilli pericellular matrices provide binding domains for interphotoreceptor retinoid-binding protein (IRBP). Exp. Eye Res. 2013, doi:10.1016/j.exer.2013.02.003.
62. Gonzalez-Fernandez, F. Evolution of the visual cycle: The role of retinoid-binding proteins. J. Endocrinol. 2002, 175, 75-88.
63. Matsumoto, H.; Yoshizawa, T. Existence of a beta-ionone ring-binding site in the rhodopsin molecule. Nature 1975, 258, 523-526.
64. Bownds, D. Site of attachment of retinal in rhodopsin. Nature 1967, 216, 1178-1181.
65. Jastrzebska, B.; Debinski, A.; Filipek, S.; Palczewski, K. Role of membrane integrity on G protein-coupled receptors: Rhodopsin stability and function. Prog. Lipid Res. 2011, 50, 267-277.
66. Masland, R.H. The neuronal organization of the retina. Neuron 2012, 76, 266-280.
67. Wassle, H. Parallel processing in the mammalian retina. Nat. Rev. Neurosci. 2004, 5, 747-757.
68. Carleton, K.L.; Spady, T.C.; Cote, R.H. Rod and cone opsin families differ in spectral tuning domains but not signal transducing domains as judged by saturated evolutionary trace analysi. J. Mol. Evol. 2005, 61, 75-89.
69. Saari, J.C.; Nawrot, M.; Garwin, G.G.; Kennedy, M.J.; Hurley, J.B.; Ghyselinck, N.B.; Chambon, P. Analysis of the visual cycle in cellular retinol-binding protein type I (CRBPI) knockout mice. Investig. Ophthalmol. Vis. Sci. 2002, 43, 1730-1735.
70. Rozanowska, M.; Handzel, K.; Boulton, M.E.; Rózanowski, B. Cytotoxicity of all-trans-retinal increases upon photodegradation. Photochem. Photobiol. 2012, 88, 1362-1372.
71. Maeda, A.; Maeda, T.; Golczak, M.; Chou, S.; Desai, A.; Hoppel, C.L.; Matsuyama, S.; Palczewski, K. Involvement of all-trans-retinal in acute light-induced retinopathy of mice. J. Biol. Chem. 2009, 284, 15173-15183.
72. Sparrow, J.R.; Boulton, M. RPE lipofuscin and its role in retinal-pathobiology. Exp. Eye Res. 2005, 80, 595-606.
73. Znoiko, S.L.; Rohrer, B.; Lu, K.; Lohr, H.R.; Crouch, R.K.; Ma, J.X. Downregulation of cone-specific gene expression and degeneration of cone Photoreceptors in the Rpe65(-/-) mouse at early ages. Investig. Ophthalmol. Vis. Sci. 2005, 46, 1473-1479.
74. Fan, J.; Rohrer, B.; Frederick, J.M.; Baehr, W.; Crouch, R.K. Rpe65(-/-) and Lrat(-/-) mice: Comparable models of Leber congenital amaurosis. Investig. Ophthalmol. Vis. Sci. 2008, 49, 2384-2389.
75. Zhang, H.; Fan, J.; Li, S.; Karan, S.; Rohrer, B.; Palczewski, K.; Frederick, J.M.; Crouch, R.K.; Baehr, W. Trafficking of membrane-associated proteins to cone photoreceptor outer segments requires the chromophore 11-cis-retinal. J. Neurosci. 2008, 28, 4008-4014.
76. Zhang, T.; Baehr, W.; Fu, Y. Chemical chaperone TUDCA preserves cone photoreceptors in a mouse model of Leber congenital amaurosis. Investig. Ophthalmol. Vis. Sci. 2012, 53, 3349-3356.
77. Sato, K.; Ozaki, T.; Ishiguro, S.; Nakazawa, M. M-opsin protein degradation is inhibited by MG-132 in Rpe65(-/-) retinal explant culture. Mol. Vis. 2012, 18, 1516-1525.
78. Batten, M.L.; Imanishi, Y.; Yu, D.C.; Doan, T.; Zhu, L.; Pang, J.J.; Glushakova, L.; Moise, A.R.; Baehr, W.; van Gelder, R.N.; et al. Pharmacological and rAAV gene therapy rescue of visual functions in a blind mouse model of Leber congenital amaurosis. PLoSMed. 2005, 2, e333.
79. Deretic, D. A role for rhodopsin in a signal transduction cascade that regulates membrane trafficking and photoreceptor polarity. Vis. Res. 2006, 46, 4427-4433.
80. Noorwez, S.M.; Malhotra, R.; McDowell, J.H.; Smith, K.A.; Krebs, M.P.; Kaushal, S. Retinoids assist the cellular folding of the autosomal dominant retinitis pigmentosa opsin mutant P23H. J. Biol. Chem. 2004, 279, 16278-16284.
81. Sakami, S.; Maeda, T.; Bereta, G.; Okano, K.; Golczak, M.; Sumaroka, A.; Roman, A.J.; Cideciyan, A.V.; Jacobson, S.G.; Palczewski, K. Probing mechanisms of photoreceptor degeneration in a new mouse model of the common form of autosomal dominant retinitis pigmentosa due to P23H opsin mutations. J. Biol. Chem. 2011, 286, 10551-10567.
82. Liu, L.; Gudas, L.J. Disruption of the lecithin:retinol acyltransferase gene makes mice more susceptible to vitamin A deficiency. J. Biol. Chem. 2005, 280, 40226-40234.
83. Perrault, I.; Rozet, J.R.; Gerber, S.; Ghazi, I.; Leowski, C.; Ducroq, D.; Souied, E.; Dufier, J.L.; Munnich, A.; Kaplan, J. Leber congenital amaurosis. Mol. Genet. Metab. 1999, 68, 200-208.
84. Hufnagel, R.B.; Ahmed, Z.M.; Corrêa, Z.M.; Sisk, R.A. Gene therapy for Leber congenital amaurosis: Advances and future directions. Graefes Arch. Clin. Exp. Ophthalmol. 2012, 250, 1117-1128.
85. Perrault, I.; Hanein, S.; Gerber, S.; Barbet, F.; Dufier, J.L.; Munnich, A.; Rozet, J.M.; Kaplan, J. Evidence of autosomal dominant Leber congenital amaurosis (LCA) underlain by a CRX heterozygous null allele. J. Med. Genet. 2003, 40, e90.
86. Den Hollander, A.I.; Roepman, R.; Koenekoop, R.K.; Cremers, F.P. Leber congenital amaurosis: Genes, proteins and disease mechanisms. Prog. Retin. Eye Res. 2008, 27, 391-419.
87. Aleman, T.S.; Jacobson, S.G.; Chico, J.D.; Scott, M.L.; Cheung, A.Y.; Windsor, E.A.; Furushima, M.; Redmond, T.M.; Bennett, J.; Palczewski, K; et al. Impairment of the transient pupillary light reflex in Rpe65(-/-) mice and humans with leber congenital amaurosis. Investig. Ophthalmol. Vis. Sci. 2004, 45, 1259-1271.
88. Lorenz, B.; Gyürüs, P.; Preising, M.; Bremser, D.; Gu, S.; Andrassi, M.; Gerth, C.; Gal, A. Early-onset severe rod-cone dystrophy in young children with RPE65 mutations. Investig. Ophthalmol. Vis. Sci. 2000, 41, 2735-2742.
89. Van Hooser, J.P.; Aleman, T.S.; He, Y.G.; Cideciyan, A.V.; Kuksa, V.; Pittler, S.J.; Stone, E.M.; Jacobson, S.G.; Palczewski, K. Rapid restoration of visual pigment and function with oral retinoid in a mouse model of childhood blindness. Proc. Natl. Acad. Sci. USA 2000, 97, 8623-8628.
90. Bainbridge, J.W.; Smith, A.J.; Barker, S.S.; Robbie, S.; Henderson, R.; Balaggan, K.; Viswanathan, A.; Holder, G.E.; Stockman, A.; Tyler, N.; et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. N. Engl. J. Med. 2008, 358, 2231-2239.
91. Van Hooser, J.P.; Liang, Y.; Maeda, T.; Kuksa, V.; Jang, G.F.; He, Y.G.; Rieke, F.; Fong, H.K.; Detwiler, P.B.; Palczewski, K. Recovery of visual functions in a mouse model of Leber congenital amaurosis. J. Biol. Chem. 2002, 277, 19173-19182.
92. Palczewski, K.; Kumasaka, T.; Hori, T.; Behnke, C.A.; Motoshima, H.; Fox, B.A.; Le, T.I.; Teller, D.C.; Okada, T.; Stenkamp, R.E; et al. Crystal structure of rhodopsin: A G protein-coupled receptor. Science 2000, 289, 739-745.
93. Palczewski, K. Retinoids for treatment of retinal diseases. Trends Pharmacol. Sci. 2010, 31, 284-295.
94. Gao, S.Q.; Maeda, T.; Okano, K.; Palczewski, K. A microparticle/hydrogel combination drug-delivery system for sustained release of retinoids. Investig. Ophthalmol. Vis. Sci. 2012, 53, 6314-6323.
95. Gearhart, P.M.; Gearhart, C.; Thompson, D.A.; Petersen-Jones, S.M. Improvement of visual performance with intravitreal administration of 9-cis-retinal in Rpe65-mutant dogs. Arch. Ophthalmol. 2010, 128, 1442-1448.
96. Collins, M.D.; Tzimas, G.; Hummler, H.; Bürgin, H.; Nau, H. Comparative teratology and transplacental pharmacokinetics of all-trans-retinoic acid, 13-cis-retinoic acid, and retinyl palmitate following daily administrations in rats. Toxicol. Appl. Pharmacol. 1994, 127, 132-144.
97. Maeda, T.; Maeda, A.; Casadesus, G.; Palczewski, K.; Margaron, P. Evaluation of 9-cis-retinyl acetate therapy in Rpe65-/- mice. Investig. Ophthalmol. Vis. Sci. 2009, 50, 4368-4378.
98. Qtaishat, N.M.; Redmond, T.M.; Pepperberg, D.R. Acute radiolabeling of retinoids in eye tissues of normal and rpe65-deficient mice. Investig. Ophthalmol. Vis. Sci. 2003, 44, 1435-1446.
99. Maeda, T.; Dong, Z.; Jin, H.; Sawada, O.; Gao, S.; Utkhede, D.; Monk, W.; Palczewska, G.; Palczewski, K. QLT091001, a 9-cis-retinal analog, is well-tolerated by retinas of mice with impaired visual cycles. Investig. Ophthalmol. Vis. Sci. 2013, 54, 455-466.
100. Maeda, T.; Cideciyan, A.V.; Maeda, A.; Golczak, M.; Aleman, T.S.; Jacobson, S.G.; Palczewski, K. Loss of cone photoreceptors caused by chromophore depletion is partially prevented by the artificial chromophore pro-drug, 9-cis-retinyl acetate. Hum. Mol. Genet. 2009, 18, 2277-2287.
101. Hamann, S.; Schorderet, D.F.; Cottet, S. Bax-induced apoptosis in leber's congenital amaurosis: A dual role in rod and cone degeneration. PLoS One 2009, 4, e6616.
102. Baxi, S.C.; Dailey, G.E. Hypervitaminosis A-A Cause of Hypercalcemia. West. J. Med. 1982, 137, 429-431.
103. Guarascio, P.; Portmann, B.; Visco, G.; Williams, R. Liver damage with reversible portal-hypertension from vitamin A intoxication: Demonstration of ito cells. J. Clin. Pathol. 1983, 36, 769-771.
104. Nollevaux, M.C.; Guiot, Y.; Horsmans, Y.; Leclercq, I.; Rahier, J.; Geubel, A.P.; Sempoux, C.; Hypervitaminosis A-induced liver fibrosis: Stellate cell activation and daily dose consumption. Liver Int. 2006, 26, 182-186.
105. Jirillo, E.; Jirillo, F.; Magrone, T. Healthy effects exerted by prebiotics, probiotics, and symbiotics with special reference to their impact on the immune system. Int. J. Vitam. Nutr. Res.2011, 82, 200-208.
106. Soprano, D.R.; Soprano, K.J. Retinoids as teratogens. Annu. Rev. Nutr. 1995, 15, 111-132.
107. Collins, M.D.; Mao, G.E. Teratology of retinoids. Annu. Rev. Pharmacol. Toxicol. 1999, 39, 399-430.
108. Rothman, K.J.; Moore, L.L.; Singer, M.R.; Nguyen, U.D.T.; Mannino, S.; Milunsky, A. Teratogenicity of high vitamin A intake. N. Engl. J. Med. 1995, 333, 1369-1373.
109. Lobo, G.P.; Amengual, J.; Baus, D.; Shivdasani, R.A.; Taylor, D.; von Lintig, J. Genetics and diet regulate vitamin A production via the homeobox transcription factor ISX. J. Biol. Chem. 2011, 288, 9017-9027.
110. Rotenstreich, Y.; Harats, D.; Shaish, A.; Pras, E.; Belkin, M. Treatment of a retinal dystrophy, fundus albipunctatus, with oral 9-cis-β-carotene. Br. J. Ophthalmol. 2010, 94, 616-621.
111. Ajmal, M.; Khan, M.I.; Neveling, K.; Khan, Y.M.; Ali, S.H.; Ahmed, W.; Iqbal, M.S.; Azam, M.; den Hollander, A.I.; Collin, R.W.; et al. Novel mutations in RDH5 cause fundus albipunctatus in two consanguineous Pakistani families. Mol. Vis. 2012, 18, 1558-1571.
112. Maeda, T.; Perusek, L.; Amengual, J.; Babino, D.; Palczewski, K.; von Lintig, J. Dietary 9-cis-β,β-carotene fails to rescue vision in mouse models of leber congenital amaurosis. Mol. Pharmacol. 2011, 80, 943-952.